Holen Sie sich die Stockscreener-App
13.40
0.30%
0.04
Schlusskurs vom Vortag:
$13.36
Offen:
$13.46
24-Stunden-Volumen:
560.32K
Relative Volume:
0.67
Marktkapitalisierung:
$770.24M
Einnahmen:
$374.64M
Nettoeinkommen (Verlust:
$87.19M
KGV:
9.8168
EPS:
1.365
Netto-Cashflow:
$90.65M
1W Leistung:
-0.67%
1M Leistung:
-4.96%
6M Leistung:
-7.97%
1J Leistung:
+0.45%
1-Tages-Spanne:
$13.29
$13.48
1-Wochen-Bereich:
$13.29
$13.60
52-Wochen-Spanne:
$12.72
$16.74
Inmode Ltd Stock (INMD) Company Profile
Compare INMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INMD
Inmode Ltd
|
13.40 | 770.24M | 374.64M | 87.19M | 90.65M | 1.365 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inmode Ltd Stock (INMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-04-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-17 | Eingeleitet | BTIG Research | Buy |
| 2024-07-23 | Herabstufung | Jefferies | Buy → Hold |
| 2023-11-03 | Herabstufung | UBS | Buy → Neutral |
| 2023-10-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-29 | Eingeleitet | UBS | Buy |
| 2023-02-17 | Herabstufung | Needham | Buy → Hold |
| 2022-12-21 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2021-05-25 | Eingeleitet | Barclays | Overweight |
| 2021-05-18 | Eingeleitet | Needham | Buy |
| 2019-09-03 | Eingeleitet | Barclays | Overweight |
| 2019-09-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-09-03 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-09-03 | Eingeleitet | UBS | Buy |
Alle ansehen
Inmode Ltd Aktie (INMD) Neueste Nachrichten
Inmode Ltd (INMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
InMode schedules annual shareholder meeting for July 30 in Israel By Investing.com - Investing.com India
InMode schedules annual shareholder meeting for July 30 in Israel - Investing.com UK
InMode (NASDAQ: INMD) outlines 2026 AGM agenda, RSU grants and committee fees - Stock Titan
Inmode Ltd (INMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Inmode Ltd (INMD) Institutional Confidence - TradingKey
Inmode Ltd (INMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Inmode Ltd (INMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Inmode Ltd (INMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Inmode Ltd (INMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Inmode Ltd (INMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Inmode Ltd (INMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Precision Trading with Inmode Ltd. (INMD) Risk Zones - Stock Traders Daily
INMD Q1 2026 Earnings: EPS Misses Estimates Despite Slight Stock UptickProfit Recovery Report - newsline.com
INMD Q1 2026 Earnings: EPS Misses Estimates by 17.4%, Stock DeclinesEarnings Miss Streak - newsline.com
InMode Investor Deadline Approaching - TMX Newsfile
InMode Q1 2026 slides: revenue beats amid margin pressure, stock falls - Investing.com
Technical Reactions to INMD Trends in Macro Strategies - Stock Traders Daily
InMode Ltd. (INMD) Presents at Jefferies Global Healthcare Conference 2026Slideshow (NASDAQ:INMD) 2026-06-04 - Seeking Alpha
INMD: Flat revenue outlook, margin pressure, and new products set the stage for future growth - TradingView
InMode Ltd stock (IL0011356806): Nasdaq shares steady as investors look ahead to next earnings updat - AD HOC NEWS
INMD Q1 2026 Earnings: EPS Misses Estimates by 17.44%, Shares Edge LowerPost-Earnings Drift - The Legal Advocate
InMode Q1 2026 earnings preview - MSN
InMode Ltd. poised for growth with new tech, global expansion, and strong financials despite US market challenges - Pluang
InMode: My Pick For A Major Turnaround In 2026 And 2027 (NASDAQ:INMD) - Seeking Alpha
Inmode Ltd (INMD) Reports Solid Numbers in a Soft Market - Insider Monkey
[Form 3] InMode Ltd. Initial Statement of Beneficial Ownership - Stock Titan
InMode (NASDAQ: INMD) CFO lists direct, spousal shares and RSU awards - Stock Titan
15 Best Micro and Small Cap Stocks to Buy According to Jim Simons’ Renaissance Technologies - Insider Monkey
INMD Q1 2026 Earnings: EPS Misses Estimates as Company Faces HeadwindsNet Income Trends - newsline.com
Trading the Move, Not the Narrative: (INMD) Edition - Stock Traders Daily
INMD Q1 2026 Earnings: Earnings Miss as EPS Falls Short of EstimatesFull Year Guidance - newsline.com
Tranche Update on InMode Ltd.'s Equity Buyback Plan announced on March 13, 2026. - marketscreener.com
INMD Stock Chart | INMODE LTD (NASDAQ:INMD) - ChartMill
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Mos - GuruFocus
INMD Technical Analysis | Trend, Signals & Chart Patterns | INMODE LTD (NASDAQ:INMD) - ChartMill
Should I Buy INMD (InMode Ltd.) | AI Analysis, Technical & News Insights - Kavout
InMode names new board chairman and CFO - Investing.com UK
InMode Ltd. Announces the Appointment of Moshik Itzkovich as Chief Financial Officer, Effective May 20, 2026 - marketscreener.com
InMode Ltd. Announces the Appointment of Shlomo Nass as Chairman of the Board of Directors , Effective May 20, 2026 - marketscreener.com
InMode Names Shlomo Nass Chair; Moshik Itzkovich Appointed as CFO - Moomoo
InMode Names Moshik Itzkovich Chief Financial Officer >INMD - Moomoo
InMode names new board chairman and CFO By Investing.com - Investing.com South Africa
InMode Reshapes Leadership with New Chairman and CFO in May 2026 - TipRanks
InMode appoints Dr. Shlomo Nass as chairman of the board and Moshik Itzkovich as chief financial officer - marketscreener.com
Leadership shakeup at InMode (Nasdaq: INMD) brings new chairman and CFO - Stock Titan
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer - PR Newswire
InMode Ltd stock (IL0011356806): shares under pressure after Q1 revenue drop and cautious outlook - AD HOC NEWS
InMode Ltd stock (IL0011356806): Q1 results keep US-focused medtech in focus - AD HOC NEWS
InMode Ltd stock (IL0011356806): Recognized among top aesthetic devices leaders - AD HOC NEWS
(INMD) Volatility Zones as Tactical Triggers - Stock Traders Daily
Finanzdaten der Inmode Ltd-Aktie (INMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):